http://orcid.org/0000-0002-1424-7843
References
- Stafstrom CE, Carmant L. Seizures and epilepsy: an overview for neuroscientists. Cold Spring Harb Perspect Med. 2015;5(6):1–18. pii: a022426.
- Saha L, Chakrabarti A. Understanding the anti-kindling role and its mechanism of resveratrol in pentylenetetrazole induced-kindling in a rat model. Pharmacol Biochem Behav. 2014;120:57–64.
- Kowski AB, Weissinger F, Gaus V, et al. Specific adverse effects of antiepileptic drugs – a true-to-life monotherapy study. Epilepsy Behav. 2016;54:150–157.
- Pahuja M, Mehla J, Kumar Gupta Y. Anticonvulsant and antioxidative activity of hydroalcoholic extract of tuber of Orchis mascula in pentylenetetrazole and maximal electroshock induced seizures in rats. J Ethnopharmacol. 2012;142(1):23–27.
- Babar ZU, Ata A, Meshkatalsadat MH. New bioactive steroidal alkaloids from Buxus hyrcana. Steroids. 2006;71(13–14):1045–1051.
- Choudhary MI, Shahnaz S, Parveen S, et al. New cholinesterase-inhibiting triterpenoid alkaloids from Buxus hyrcana. Chem Biodivers. 2006;3(9):1039–1052.
- Esmaeili S, Naghibi F, Mosaddegh M, et al. Screening of antiplasmodial properties among some traditionally used Iranian plants. J Ethnopharmacol. 2009;121(3):400–404.
- Ata A, Iverson CD, Kalhari KS, et al. Triterpenoidal alkaloids from Buxus hyrcana and their enzyme inhibitory, anti-fungal and anti-leishmanial activities. Phytochemistry. 2010;71(14–15):1780–1786.
- Ebrahimzadeh MA, Nabavi SM, Nabavi SF, et al. Antioxidant and free radical scavenging activity of H. officinalis L. var. angustifolius, V. odorata, B. hyrcana and C. speciosum. Pak J Pharm Sci. 2010;23(1):29–34.
- Mesaik MA, Halim SA, Ul-Haq Z, et al. Immunosuppressive activity of buxidin and E-buxenone from Buxus hyrcana. Chem Biol Drug Des. 2010;75(3):310–317.
- Choudhary MI, Shahnaz S, Parveen S, et al. New Triterpenoid alkaloid cholinesterase inhibitors from Buxus hyrcana. J Nat Prod. 2003;66(6):739–742.
- Hosseini A, Mirazi N. Alteration of pentylenetetrazole-induced seizure threshold by chronic administration of ginger (Zingiber officinale) extract in male mice. Pharm Biol. 2015;53(5):752–757.
- Uyanıkgil Y, Solmaz V, Çavuşoğlu T, et al. Inhibitor effect of paricalcitol in rat model of pentylenetetrazol-induced seizures. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(10):1117–1122.
- Karimzadeh F, Hosseini M, Mangeng D, et al. Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain. BMC Complement Altern Med. 2012;12:76.
- Aracri P, Meneghini S, Coatti A, et al. α4β2∗ nicotinic receptors stimulate GABA release onto fast-spiking cells in layer V of mouse prefrontal (Fr2) cortex. Neuroscience. 2017;340:48–61.
- Mandhane SN, Aavula K, Rajamannar T. Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice. Seizure. 2007;16(7):636–644.
- Khazipov R. GABAergic synchronization in epilepsy. Cold Spring Harb Perspect Med. 2016;6(2):a022764.
- Kherani ZS, Auer RN. Pharmacologic analysis of the mechanism of dark neuron production in cerebral cortex. Acta Neuropathol. 2008;116(4):447–452.
- Ebrahimzadeh Bideskan AR, Lale Ataei M, Mansouri S, et al. The effects of tamoxifen and soy on dark neuron production in hippocampal formation after pentylenetetrazole-induced repeated seizures in rats. Pathophysiology. 2015;22(2):125–135.
- Jaworski T, Lechat B, Demedts D, et al. Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. Am J Pathol. 2011;179(4):2001–2015.
- Rao RS, Medhi B, Khanduja KL, et al. Correlation of seizures and biochemical parameters of oxidative stress in experimentally induced inflammatory rat models. Fundam Clin Pharmacol. 2010;24(3):325–331.
- Cárdenas-Rodríguez N, Coballase-Urrutia E, Pérez-Cruz C, et al. Relevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental models. Oxid Med Cell Longev. 2014;2014:759293.
- Li G, Bauer S, Nowak M, et al. Cytokines and epilepsy. Seizure. 2011;20(3):249–256.